|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Pretransplantation therapy with azacitidine vs induction chemotherapy and posttransplantation outcome in patients with MDS 显示文摘 | Gerds AT Gooley TA Estey EH | 2012 | Biol Blood Marrow Transplant2012，18，8： | 1 |
| 2 | Plasma vascular endothelial growth factgor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndrome显示文摘 | Aguayo A Kantarjian HM Estey EH | 2002 | Cancer2002，95，： | 1 |
| 3 | Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes 显示文摘 | Aguayo A Kantarjian HM Estey EH Giles FJ Verstovsek S Manshouri T | 2002 | Cancer2002，95，9： | 1 |
| 4 | Combination therapy with arsenic trioxide, all-trans retinoic acid, and gemtuzumabozogamicin in recurrent acute promyelocytic leukemia显示文摘 | Aribi A Kantarjian HM Estey EH | 2007 | Cancer2007，109，7： | 1 |
| 5 | Epigenetics in clinical practice:the examples of azacitidine and decitabine in myelodysplasia and acute myeloid leukemia显示文摘 | Estey EH | 2013 | Leukemia2013，27，9： | 1 |
| 6 | Experience with gemtuzumab ozogamycin ('mylotarg') and all-trans retinoic acid in untreated acute promyelocytic leukemia显示文摘 | Estey EH Giles FJ Beran M | 2002 | Blood2002，99，： | 1 |
| 7 | Acute myeloid leukemia:2013 update on risk-stratification and management显示文摘 | Estey EH | 2013 | Am J Hematol2013，88，4： | 1 |
| 8 | Diagnosis and management of acute myeloid leukemia in adults:recommendations from an international expert panel,on behalf of the European LeukemiaNet显示文摘 | Dhner H Estey EH Amadori S Appelbaum FR Büchner T Burnett AK Dombret H Fenaux P Grimwade D Larson RA Lo-Coco F Naoe T Niederwieser D Ossenkoppele GJ Sanz MA Sierra J Tallman MS Lwenberg B Bloomfield CD | 2010 | {H}Blood2010，，03： | 1 |
| 9 | Comparison of idarubicin + ara-C-, fludarabine + ara-C-, and topotecan + ara-C-based regimens in treatment of newly diagnosed acute myeloid leukemia, refractory anemia with excess blasts in transformation, or refractory anemia with excess blasts显示文摘 | Thall PF Cortes JE | 2001 | Blood2001，98，13： | 1 |
| 10 | Therapeutic options for acute myelogenous leukemia显示文摘 | Estey EH | 2001 | Caneer2001，92，5： | 1 |
| 11 | Treatment of advanced stages of Philadelphia chromosome-positive chronic myelogenous leukemia with interferon-alpha and low-dose cytarabine显示文摘 | Kantarjian HM Keating MJ Estey EH | 1992 | J Clin Oncol1992，10，5： | 1 |
| 12 | Modulation of angiogenesis in patients withmyelodysplastic syndrome显示文摘 | | 2004 | Best Pract Res Clin Haematol2004，17，4： | 1 |
| 13 | Diagnosis and management of acute myeloid leukemia in adults:recommendations from an international expert panel,on behalf of the European LeukemiaNet显示文摘 | DOHNER H ESTEY EH AMADORI S | 2010 | Blood2010，115，3： | 1 |
| 14 | Combination therapy with arsenic trioxide,all-trans retinoic acid,and gemtuzum ab ozogamicin in recurrent acute promyelocytic leukemia显示文摘 | ARIBI A KANTARJIAN HM ESTEY EH | 2007 | Cancer2007，109，7： | 1 |
| 15 | Acute myeloid leukemia: 2012 update on dia- gnosis, risk stratification, and management显示文摘 | Estey EH | 2012 | Am J Hema- tol2012，87，1： | 1 |
| 16 | Epidemiology ofmyelodysplas- tic syndromes显示文摘 | Strom SS Ve fez-Bravo V Estey EH | 2008 | Semin Hematol2008，45，1： | 1 |
| 17 | How I treat older patients with AML显示文摘 | Estey EH | 2000 | Blood2000，96，5： | 1 |
| 18 | Epigenetics in clinical practice:the examples of azacitidine and decitabine in myelodysplasia and acute myeloid leukemia显示文摘 | Estey EH | 2013 | Leukemia2013，27，9： | 1 |
| 19 | Molecular remissions induced by liposomalencapsulated all-trans retinoic acid in newly diagnosed acute promyelocytic leukemia显示文摘 | Estey EH Giles FJ Kantarjian H | | 0，，07： | 1 |
| 20 | Thrombosis in patients with acute promyelocytic leukemia treated with and without all-trans retinoic acid显示文摘 | Kantarjian HM Estey EH | 1996 | Leuk Lymphoma1996，20，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员